Autus Asset Management’s Allergan Inc AGN Stock Holding History

Autus Asset Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-45,516	Closed	-$5.65M	–	122
2014 Q1	$5.65M	Sell	45,516 -1,051	-2%	-$128K	2.14%	13
2013 Q4	$5.17M	Buy	46,567 +835	+2%	+$79.8K	2.02%	15
2013 Q3	$4.14M	Buy	45,732 +3,205	+8%	+$288K	1.75%	23
2013 Q2	$3.58M	Buy	+42,527	New	+$4.41M	1.61%	29

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Autus Asset Management's AGN Position: Q2 2014 in Review

Autus Asset Management sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 45,516 shares — an estimated $5.65M sold.

Autus Asset Management first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $5.65M in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

Autus Asset Management reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
Autus Asset Management sold 45,516 Allergan Inc shares in Q2 2014, an estimated $5.65M.
Autus Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
Autus Asset Management's Allergan Inc position peaked at $5.65M in Q1 2014.
770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Autus Asset Management's 13F filing for Q2 2014, filed 1 Aug 2014.